Evidence map›Paper›PMID 40352551›Full record

ArticleACS omega2025

Particle Size-Controllable Preparation of a CL-20/HMX Cocrystal with High Energy and Low Sensitivity.

SongYuChen Ma, Tao Liu, DeQi Wang, YinHui Li, WenJing Shi, FengSheng Li, Jie Liu

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

SongYuChen MaSchool of Chemistry and Chemical Engineering, National Special Superfine Powder Engineering Research Center, Nanjing University of Science and Technology, Nanjing, Jiangsu 210094, China.
Tao LiuSchool of Chemistry and Chemical Engineering, National Special Superfine Powder Engineering Research Center, Nanjing University of Science and Technology, Nanjing, Jiangsu 210094, China.
DeQi WangSchool of Chemistry and Chemical Engineering, National Special Superfine Powder Engineering Research Center, Nanjing University of Science and Technology, Nanjing, Jiangsu 210094, China.
YinHui LiSchool of Chemistry and Chemical Engineering, National Special Superfine Powder Engineering Research Center, Nanjing University of Science and Technology, Nanjing, Jiangsu 210094, China.
WenJing ShiSchool of Chemistry and Chemical Engineering, National Special Superfine Powder Engineering Research Center, Nanjing University of Science and Technology, Nanjing, Jiangsu 210094, China.
FengSheng LiSchool of Chemistry and Chemical Engineering, National Special Superfine Powder Engineering Research Center, Nanjing University of Science and Technology, Nanjing, Jiangsu 210094, China.
Jie LiuSchool of Chemistry and Chemical Engineering, National Special Superfine Powder Engineering Research Center, Nanjing University of Science and Technology, Nanjing, Jiangsu 210094, China.ORCID https://orcid.org/0000-0001-6912-0797

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To address the quality issues arising from the uncontrollable morphological grain size in the preparation of CL-20/HMX cocrystals, a novel method for producing high-quality cocrystals with well-defined morphological grain sizes has been developed. The cocrystallization process was conducted using the solvent/nonsolvent method, wherein the mixing efficiency and solution supersaturation were precisely controlled through systematic optimization of key parameters, including solvent composition, solvent/nonsolvent ratio, reaction temperature, and stirring rate. Through systematic optimization of experimental parameters, three distinct rhombohedral CL-20/HMX cocrystal samples with uniform particle size distributions and well-defined morphologies were successfully prepared, exhibiting characteristic

Identifiers

PMID40352551
PMCPMC12060048

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.